Benedetta Pellegrino
8PUBLICATIONS
111CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 19, 2025
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino
|Mar 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer.Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino
|Dec 16, 2024
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi
|Jul 28, 2023
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.Claire Jh Kramer, Alba Llop-Guevara, Elisa Yaniz-Galende
|May 02, 2023
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio
|Apr 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara
Pageof 2
Frequent Collaborators
4 joint publications
Violeta Serra
3 joint publications
Alba Llop-Guevara
3 joint publications
Antonino Musolino
2 joint publications
Mark J O'Connor
2 joint publications
Paolo Nuciforo
2 joint publications
Judith Balmaña
1 joint publications
Angela Celetti
1 joint publications
Andrea Degasperi
1 joint publications
João M L Dias
1 joint publications
Josep V Forment
